home / stock / medxf / medxf message board
Subject | By | Source | When |
---|---|---|---|
Any thoughts on the quarter? | rado | investorshub | 08/17/2021 8:55:33 PM |
Wow! A post?? Yeah, amazing potential. Going much higher | ronpopeil | investorshub | 06/12/2021 12:11:50 AM |
Let's gooooo $MEDXF | Phils Goodman | investorshub | 06/11/2021 11:47:30 PM |
I like this one a lot. Strong revenues. | ronpopeil | investorshub | 04/22/2021 8:29:43 PM |
started a new position last week and up | arnoldisking | investorshub | 03/16/2021 9:40:12 PM |
Gonna be a great 2021 :) | arch1inc | investorshub | 03/14/2021 3:16:59 AM |
i like this stonk | gallegly | investorshub | 03/14/2021 12:59:27 AM |
I purchased based on part on Archer's DD. | Trouble w/ Tribbles | investorshub | 03/11/2021 3:57:42 PM |
News, Short Squeeze, Breakout and More Instantly...
Medexus Pharmaceuticals Inc Company Name:
MEDXF Stock Symbol:
OTCMKTS Market:
Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - May 1, 2024) - Following a trial in January 2023, Canada's Federal Court has issued a judgment declining to uphold the Canadian patent for Metoject®. Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) and medac, licensor of Medexus's c...
Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - April 2, 2024) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) is pleased to announce that company management will be participating in the 2024 Bloom Burton & Co. Healthcare Investor Conference from April 16 to 17, 2024. Event : ...
Expanded indication includes patients under 12 years of age, based on Phase 3/4 data demonstrating safety and efficacy in previously treated patients in this age group Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - March 26, 2024) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) to...